Leerink and Oppenheimer acted as joint book running managers for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMRX:
- Promising Clinical Trial Results and Favorable Safety Profile Support Buy Rating for Immuneering
- Immuneering Announces $25M Securities Purchase Agreement
- Immuneering announces data from trial of atebimetinib combination
- Immuneering announces Class A common stock offering, private placement
- Immuneering appoints Schall as Chairman of the Board